Overview

 

Although prostate cancer affects older men, it is not uncommon to find younger men with this disease especially with a strong family history. It is the most common cancer in men in the UK. Over 40,000 new cases are diagnosed every year.

Diagnosis

Most prostate cancers are incidentally diagnosed but some men can experience urinary symptoms. PSA (Prostate Specific Antigen) is an important screening blood test selectively used to screen men with suspected prostate cancer. An assessment of the prostate through a rectal examination by a urologist gives an estimate about the size of the prostate as well as the texture of the prostate gland which might prompt further tests such as MRI scan and biopsies of the prostate to rule out cancer.

Treatment

Watch and Wait or Surveillance

For some men, they may be advised to simply watch their symptoms and if they get worse, seek treatment. This is because it may not affect their life expectancy and if the symptoms are not particularly painful or difficult to live with, it may be better to avoid treatment. Furthermore, if a man is not in good health, this may be the best approach.

There may be some men who undergo surveillance, which is regular PSA tests and scans to ensure that any developments in the cancer are discovered as soon as possible. Where it does get worse, they will then need to progress to another treatment option.

Surgery

Complete removal of the prostate gland or radical prostatectomy is usually done for prostate cancer as a curative treatment. For more information on how this is carried out, please see our dedicated page for prostatectomy.

Transurethral Resection of the Prostate (TURP)

A telescope is passed down the urethra to cut away prostate tissue causing an obstruction to the urinary flow with an electric loop. It can relieve pressure from the urethra and treats symptoms associated with urination, but it will not cure the cancer.

SpaceOAR

SpaceOAR is an absorbable hydrogel used to reduce rectal side effects following radiotherapy in prostate cancer patients. The hdyrogel or prerectal spacer not only reduces the rectal toxicity but also helps to reduce urinary toxicity and sexual dysfunction after radiotherapy.

The spacer is inserted under a short general anaesthetic through the perineum in between the rectum and the prostate. The recovery period is 24-48 hours. The procedure has got minimal after-effects. Occasionally the patient can experience rectal fullness, urinary burning, perineal bruising and very rarely retention.

Meet our specialists

Mr Rajiv Pillai

MSc MS FRCS (Urol) FEBU

Read more
Mr Sam Datta

BSc MSc MD FRCS (Urol) PGCME

Read more
Mr Zafar Maan

BSc (Hons) MSc (Urol) MA (Clin Ed) FRCS (Urol)

Read more

Make an enquiry

Whether you are ready to book an appointment or if you wish to speak to a member of our team regarding what service you may require or about any questions you have, simply fill out the form with your details and we will get back to you.

If you would like to speak to us directly or want to make an appointment immediately, then call us on:

07580 307020

pas@aua.ltd

By submitting this form, you consent to us processing your data in order to respond to your enquiry. Read our privacy policy for more information.

Throughout my admission I found the nursing staff extremely pleasant and nothing was too much trouble. After the surgery the surgeon personally telephoned my wife and informed her of my condition which I thought was a very caring thing to do, after what was obviously very long day for them. They could have delegated this task but didn’t. All in all I was very impressed with the service supplied.

– Mr J, Colchester